HIV abnormal immune activation and immunomodulatory therapy
Affiliated HospitalPeking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Research areas: Diagnosis and treatment of infectious diseases and fever of unknown origin; abnormal immune activation and immunomodulatory therapy in HIV infection.
Cutting-edge technology: From 2014 to 2015, I conducted postdoctoral research at McGill University School of Medicine in Canada, focusing on clinical studies related to acute HIV infection. As one of the corresponding authors, I participated in the development of a treatment regimen combining intravenous immunoglobulin and low molecular weight heparin for critically ill COVID-19 patients. I have published over 10 SCI papers in journals such as CID, JAIDS, and J Clin Virol.
Areas of expertise: Diagnosis and treatment of infectious diseases and fever of unknown origin; treatment of HIV and infections in immunocompromised individuals.
Academic Highlights and Core Values: Deputy Director and Chief Physician of the Department of Infectious Diseases. Member and Deputy Secretary-General of the Chinese Society of Infectious Diseases, and Member of the Chinese Society of Tropical Diseases and Parasitology. Has conducted in-depth research in the field of HIV abnormal immune activation mechanisms and immunomodulatory therapy.